Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 18 studies | 33% ± 10% | |
lung | 13 studies | 26% ± 9% | |
intestine | 11 studies | 27% ± 10% | |
kidney | 7 studies | 33% ± 11% | |
eye | 7 studies | 29% ± 13% | |
liver | 6 studies | 40% ± 21% | |
lymph node | 6 studies | 34% ± 11% | |
bone marrow | 5 studies | 44% ± 25% | |
uterus | 5 studies | 29% ± 7% | |
breast | 4 studies | 21% ± 4% | |
placenta | 3 studies | 28% ± 15% | |
ovary | 3 studies | 28% ± 4% | |
brain | 3 studies | 24% ± 1% | |
skin | 3 studies | 20% ± 2% | |
thymus | 3 studies | 55% ± 23% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
uterus | 100% | 4268.86 | 170 / 170 | 100% | 387.22 | 457 / 459 |
intestine | 100% | 4572.67 | 966 / 966 | 99% | 199.25 | 522 / 527 |
lung | 100% | 4656.17 | 576 / 578 | 99% | 145.97 | 1147 / 1155 |
breast | 100% | 4800.26 | 459 / 459 | 99% | 200.46 | 1106 / 1118 |
bladder | 100% | 3646.05 | 21 / 21 | 98% | 212.19 | 496 / 504 |
thymus | 100% | 3192.33 | 651 / 653 | 98% | 241.84 | 593 / 605 |
ovary | 100% | 5915.29 | 180 / 180 | 98% | 128.74 | 420 / 430 |
esophagus | 100% | 4133.69 | 1445 / 1445 | 97% | 140.26 | 178 / 183 |
prostate | 100% | 2580.04 | 244 / 245 | 93% | 67.05 | 466 / 502 |
skin | 100% | 5192.27 | 1808 / 1809 | 92% | 120.02 | 435 / 472 |
brain | 93% | 1832.50 | 2457 / 2642 | 97% | 118.20 | 685 / 705 |
stomach | 91% | 2382.21 | 328 / 359 | 99% | 160.74 | 282 / 286 |
kidney | 99% | 2472.00 | 88 / 89 | 90% | 69.33 | 811 / 901 |
adrenal gland | 83% | 1198.92 | 214 / 258 | 90% | 76.82 | 206 / 230 |
pancreas | 43% | 518.33 | 141 / 328 | 96% | 111.68 | 170 / 178 |
liver | 41% | 553.46 | 93 / 226 | 64% | 53.98 | 259 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 451.55 | 29 / 29 |
spleen | 100% | 8163.68 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 363.44 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 102.46 | 1 / 1 |
blood vessel | 100% | 3855.80 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 4712.17 | 1203 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 14167.30 | 927 / 929 | 0% | 0 | 0 / 0 |
heart | 94% | 2209.67 | 809 / 861 | 0% | 0 | 0 / 0 |
muscle | 87% | 2047.78 | 700 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 16% | 7.61 | 13 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006325 | Biological process | chromatin organization |
GO_0006303 | Biological process | double-strand break repair via nonhomologous end joining |
GO_0032728 | Biological process | positive regulation of interferon-beta production |
GO_0045654 | Biological process | positive regulation of megakaryocyte differentiation |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0045087 | Biological process | innate immune response |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0050829 | Biological process | defense response to Gram-negative bacterium |
GO_0050918 | Biological process | positive chemotaxis |
GO_0033151 | Biological process | V(D)J recombination |
GO_0008625 | Biological process | extrinsic apoptotic signaling pathway via death domain receptors |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0007289 | Biological process | spermatid nucleus differentiation |
GO_0002437 | Biological process | inflammatory response to antigenic stimulus |
GO_0045089 | Biological process | positive regulation of innate immune response |
GO_0006334 | Biological process | nucleosome assembly |
GO_0072091 | Biological process | regulation of stem cell proliferation |
GO_0050830 | Biological process | defense response to Gram-positive bacterium |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0001938 | Biological process | positive regulation of endothelial cell proliferation |
GO_0006265 | Biological process | DNA topological change |
GO_0045648 | Biological process | positive regulation of erythrocyte differentiation |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0008584 | Biological process | male gonad development |
GO_0048545 | Biological process | response to steroid hormone |
GO_0032392 | Biological process | DNA geometric change |
GO_1902042 | Biological process | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors |
GO_0050767 | Biological process | regulation of neurogenesis |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0060326 | Biological process | cell chemotaxis |
GO_0032496 | Biological process | response to lipopolysaccharide |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005730 | Cellular component | nucleolus |
GO_0005615 | Cellular component | extracellular space |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0000793 | Cellular component | condensed chromosome |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0008134 | Molecular function | transcription factor binding |
GO_0003677 | Molecular function | DNA binding |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0008301 | Molecular function | DNA binding, bending |
GO_0019904 | Molecular function | protein domain specific binding |
GO_0000987 | Molecular function | cis-regulatory region sequence-specific DNA binding |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_0003697 | Molecular function | single-stranded DNA binding |
GO_0003690 | Molecular function | double-stranded DNA binding |
GO_0000400 | Molecular function | four-way junction DNA binding |
GO_0042056 | Molecular function | chemoattractant activity |
GO_0097100 | Molecular function | supercoiled DNA binding |
GO_0003723 | Molecular function | RNA binding |
GO_0044378 | Molecular function | non-sequence-specific DNA binding, bending |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0050786 | Molecular function | RAGE receptor binding |
GO_0005515 | Molecular function | protein binding |
GO_0003684 | Molecular function | damaged DNA binding |
Gene name | HMGB2 |
Protein name | High mobility group protein B2 (High mobility group protein 2) High mobility group protein B2 (High mobility group protein 2) (HMG-2) |
Synonyms | HMG2 |
Description | FUNCTION: Multifunctional protein with various roles in different cellular compartments. May act in a redox sensitive manner. In the nucleus is an abundant chromatin-associated non-histone protein involved in transcription, chromatin remodeling and V(D)J recombination and probably other processes. Binds DNA with a preference to non-canonical DNA structures such as single-stranded DNA. Can bent DNA and enhance DNA flexibility by looping thus providing a mechanism to promote activities on various gene promoters by enhancing transcription factor binding and/or bringing distant regulatory sequences into close proximity . Involved in V(D)J recombination by acting as a cofactor of the RAG complex: acts by stimulating cleavage and RAG protein binding at the 23 bp spacer of conserved recombination signal sequences (RSS) (By similarity). Proposed to be involved in the innate immune response to nucleic acids by acting as a promiscuous immunogenic DNA/RNA sensor which cooperates with subsequent discriminative sensing by specific pattern recognition receptors (By similarity). In the extracellular compartment acts as a chemokine. Promotes proliferation and migration of endothelial cells implicating AGER/RAGE . Has antimicrobial activity in gastrointestinal epithelial tissues . Involved in inflammatory response to antigenic stimulus coupled with pro-inflammatory activity (By similarity). Involved in modulation of neurogenesis probably by regulation of neural stem proliferation (By similarity). Involved in articular cartilage surface maintenance implicating LEF1 and the Wnt/beta-catenin pathway (By similarity). . |
Accessions | ENST00000296503.10 D6R9A6 ENST00000506267.1 P26583 ENST00000438704.6 ENST00000446922.6 |